Physician profile
Mark C Lentner
NPI 1205197407
$2,000.92
in general payments reported to CMS, 2019-2025
16 companies · $393 in 2025
The $393 reported for 2025 was more than what a typical Otolaryngology/Facial Plastic Surgery provider received nationally (typical 2025 total: $305).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $236 · 2020: $104 · 2021: $350 · 2022: $464 · 2023: $160 · 2024: $294 · 2025: $393.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $847.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $846.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $384.22 | 2021-2025 | Nucala |
| Optinose US, INC. | $279.17 | 2020-2025 | |
| Organogenesis INC. | $248.44 | 2022-2025 | Puraply, Puraply Wound Matrix, Cygnus Dual |
| Stryker Corporation | $189.16 | 2019-2025 | Scopis Ent, Stryker Nav3 |
| Kaleo, INC. | $163.65 | 2020-2022 | |
| Intersect Ent, INC. | $150.00 | 2019 | |
| Inspire Medical Systems, INC. | $148.28 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $120.24 | 2019-2024 | Dupixent |
| Smith+Nephew, INC. | $92.31 | 2022-2025 | Oasis, Stravix Pl, Stravix |
| Genzyme Corporation | $64.50 | 2019-2022 | |
| Aerin Medical INC. | $43.60 | 2019-2024 | |
| Astrazeneca Pharmaceuticals LP | $31.09 | 2025 | Tezspire |
| Integra Lifesciences Corporation | $25.12 | 2024 | Codman Isocool Aht, Integra Duo, Microfrance |
| Amgen INC. | $24.19 | 2025 | Tezspire |
| Ambu INC. | $19.98 | 2024 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Uswm, LLC | $16.97 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Lentner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.